nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis
|
Bergmeier, Wolfgang |
|
|
2 |
3 |
p. 407-428 |
artikel |
2 |
Assessment of limb edema in pediatric post‐thrombotic syndrome
|
Avila, Maria L. |
|
|
2 |
3 |
p. 591-595 |
artikel |
3 |
Associations between illness beliefs, medication beliefs, anticoagulation‐related quality of life, and INR control: Insights from the Switching Study
|
Bartoli‐Abdou, John K. |
|
|
2 |
3 |
p. 497-507 |
artikel |
4 |
A survey of characteristics and current educational needs of hemophilia treatment centers within Asia Pacific
|
Lam, Joyce C.M. |
|
|
2 |
3 |
p. 508-517 |
artikel |
5 |
Cyclic nucleotide‐dependent inhibitory signaling interweaves with activating pathways to determine platelet responses
|
Nagy, Zoltan |
|
|
2 |
3 |
p. 558-571 |
artikel |
6 |
Effectiveness of a training program for bleeding disorders among accredited social health activists in Udupi District, Karnataka, India
|
Badagabettu, Sulochana |
|
|
2 |
3 |
p. 518-524 |
artikel |
7 |
Electronic alerts, comparative practitioner metrics, and education improve thromboprophylaxis and reduce venous thrombosis in community hospitals
|
Woller, Scott C. |
|
|
2 |
3 |
p. 481-489 |
artikel |
8 |
Extended anticoagulation for unprovoked venous thromboembolism
|
Castellucci, Lana A. |
|
|
2 |
3 |
p. 529-534 |
artikel |
9 |
Focusing in on use of pharmacokinetic profiles in routine hemophilia care
|
Croteau, Stacy E. |
|
|
2 |
3 |
p. 607-614 |
artikel |
10 |
Illustrated review article: A new format for disseminating scientific progress
|
Wolberg, Alisa S. |
|
|
2 |
3 |
p. 405-406 |
artikel |
11 |
Imaging platelet biogenesis in vivo
|
Schulze, Harald |
|
|
2 |
3 |
p. 461-468 |
artikel |
12 |
Immigration, region of origin, and the epidemiology of venous thromboembolism: A population‐based study
|
Lazo‐Langner, Alejandro |
|
|
2 |
3 |
p. 469-480 |
artikel |
13 |
Integrating platelet and coagulation activation in fibrin clot formation
|
Swieringa, Frauke |
|
|
2 |
3 |
p. 450-460 |
artikel |
14 |
ISSUE INFORMATION
|
|
|
|
2 |
3 |
p. i, 401-404 |
artikel |
15 |
Managing thrombosis in cancer patients
|
Wang, Tzu‐Fei |
|
|
2 |
3 |
p. 429-438 |
artikel |
16 |
Matrix metalloproteinase‐13 unlucky for the forming thrombus
|
Montague, Samantha J. |
|
|
2 |
3 |
p. 525-528 |
artikel |
17 |
MiR‐21 role in aspirin‐dependent PPARα and multidrug resistance protein 4 upregulation
|
Massimi, Isabella |
|
|
2 |
3 |
p. 596-606 |
artikel |
18 |
Novel aspects of antiplatelet therapy in cardiovascular disease
|
Gremmel, Thomas |
|
|
2 |
3 |
p. 439-449 |
artikel |
19 |
Out‐of‐range INR results lead to increased health‐care utilization in four large anticoagulation clinics
|
Barnes, Geoffrey D |
|
|
2 |
3 |
p. 490-496 |
artikel |
20 |
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations
|
Iorio, Alfonso |
|
|
2 |
3 |
p. 535-548 |
artikel |
21 |
Phase 3, single‐arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design
|
Luciani, Matteo |
|
|
2 |
3 |
p. 580-590 |
artikel |
22 |
Pilot trials in thrombosis: Purpose and pitfalls
|
Ikesaka, Rick |
|
|
2 |
3 |
p. 572-579 |
artikel |
23 |
The coagulation system in host defense
|
Antoniak, Silvio |
|
|
2 |
3 |
p. 549-557 |
artikel |